Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × OTHER × Dysbiosis × Clear all

Phase

Status

Recruiting 4 Completed 4 Unknown 2 Not yet recruiting 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 55 Neoplasms 44 Colorectal Neoplasms 30 Prostatic Neoplasms 27 Lung Neoplasms 20 Carcinoma, Non-Small-Cell Lung 17 Carcinoma, Hepatocellular 14 Stomach Neoplasms 12 Uterine Cervical Neoplasms 11 Anxiety Disorders 11 Lymphoma, Follicular 10 Brain Neoplasms 10 Pancreatic Neoplasms 9 Motor Activity 8 Colonic Neoplasms 8 Cholangiocarcinoma 8 Barrett Esophagus 8 Urinary Bladder Neoplasms 7 Rectal Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Sarcoma 6 Ovarian Neoplasms 6 Leukemia, Myeloid, Acute 6 Head and Neck Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Depression 6 Thyroid Diseases 5 Recurrence 5 Pain 5

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡